NRG-BN010: A SAFETY RUN-IN AND PHASE II STUDY EVALUATING THE COMBINATION OF TOCILIZUMAB, ATEZOLIZUMAB, AND FRACTIONATED STEREOTACTIC RADIOTHERAPY IN RECURRENT GLIOBLASTOMA - TRIAL IN PROGRESS Conference

Bagley, Stephen, Polley, Mei-Yin, Kotecha, Rupesh et al. (2022). NRG-BN010: A SAFETY RUN-IN AND PHASE II STUDY EVALUATING THE COMBINATION OF TOCILIZUMAB, ATEZOLIZUMAB, AND FRACTIONATED STEREOTACTIC RADIOTHERAPY IN RECURRENT GLIOBLASTOMA - TRIAL IN PROGRESS . NEURO-ONCOLOGY, 24 64-64.

cited authors

  • Bagley, Stephen; Polley, Mei-Yin; Kotecha, Rupesh; Brem, Steven; Tolakanahalli, Ranjini; Iwamoto, Fabio; Gilbert, Mark; Won, Minhee; Mehta, Minesh

authors

date/time interval

  • November 16, 2022 -

publication date

  • November 1, 2022

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • FL, Tampa

Conference

  • 27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 64

end page

  • 64

volume

  • 24